Table 15.4b

Steroid Avoidance Rate at Discharge, 1997 to 2006

Recipients of Living Donor Kidneys

Discharge Regimen Year of Transplant
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
Total Patients 3,456 3,871 4,072 4,720 5,186 5,355 5,506 5,681 5,552 5,454
Steroids Avoided 106 147 118 262 464 633 1,015 1,607 1,815 2,056
Rate 3.1% 3.8% 2.9% 5.6% 8.9% 11.8% 18.4% 28.3% 32.7% 37.7%
CyA Patients 259 232 235 167 123 80 104 122 26 28
Steroids Avoided 14 8 1 4 8 4 10 20 6 10
Rate 5.4% 3.4% 0.4% 2.4% 6.5% 5.0% 9.6% 16.4% 23.1% 35.7%
Tac Patients 87 100 120 203 220 233 190 197 136 189
Steroids Avoided 3 5 5 30 46 87 64 68 56 113
Rate 3.4% 5.0% 4.2% 14.8% 20.9% 37.3% 33.7% 34.5% 41.2% 59.8%
CyA+MMF Patients 1,824 1,951 2,046 1,923 1,639 1,298 1,121 954 710 500
Steroids Avoided 25 42 36 64 66 44 111 123 113 117
Rate 1.4% 2.2% 1.8% 3.3% 4.0% 3.4% 9.9% 12.9% 15.9% 23.4%
Tac+MMF Patients 305 764 1,018 1,393 1,977 2,596 2,881 3,338 3,843 3,919
Steroids Avoided 7 38 48 73 132 261 477 1,005 1,335 1,543
Rate 2.3% 5.0% 4.7% 5.2% 6.7% 10.1% 16.6% 30.1% 34.7% 39.4%
CyA+Aza Patients 581 405 270 186 144 51 20 14 5 6
Steroids Avoided 20 23 7 3 2 0 1 1 1 1
Rate 3.4% 5.7% 2.6% 1.6% 1.4% 0.0% 5.0% 7.1% 20.0% 16.7%
Tac+Aza Patients 43 68 61 59 84 82 70 41 9 16
Steroids Avoided 1 1 3 5 11 6 7 6 3 7
Rate 2.3% 1.5% 4.9% 8.5% 13.1% 7.3% 10.0% 14.6% 33.3% 43.8%
Siro+MMF Patients - 2 1 45 109 152 154 108 131 85
Steroids Avoided - 0 0 12 8 6 22 26 20 16
Rate - 0.0% 0.0% 26.7% 7.3% 3.9% 14.3% 24.1% 15.3% 18.8%
CyA+Siro Patients 45 88 60 260 170 142 168 129 148 134
Steroids Avoided 1 1 0 1 5 30 60 81 103 111
Rate 2.2% 1.1% 0.0% 0.4% 2.9% 21.1% 35.7% 62.8% 69.6% 82.8%
Tac+Siro Patients - - 6 217 429 382 370 324 211 253
Steroids Avoided - - 0 22 103 94 115 145 79 64
Rate - - 0.0% 10.1% 24.0% 24.6% 31.1% 44.8% 37.4% 25.3%
Other Regimen Patients 312 261 255 267 291 339 428 454 333 324
Steroids Avoided 35 29 18 48 83 101 148 132 99 74
Rate 11.2% 11.1% 7.1% 18.0% 28.5% 29.8% 34.6% 29.1% 29.7% 22.8%


Source: OPTN/SRTR Data as of May 1, 2007.

Includes patients receiving first transplants of any organ with a functioning graft at discharge and any immunosuppressive drug use recorded at discharge.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine; Siro: Sirolimus.